Chimeric Therapeutics is trading 16.67% up at A$0.01 after recent heavy selling, although the catalyst remains unclear.
- No verified company-specific announcement was identified for September 8, 2026; the ASX daily-announcements search shows no Chimeric release.
- The latest identifiable share-issuance news dates to September 4.
- The broader September 8 session was weaker; the move may reflect a technical rebound or speculative activity, but no direct cause is confirmed.